Clinical Trial

Comparing Doses of Intrathecal Dexmedetomidine

Completed Phase 4
View on ClinicalTrials.gov →
Summary
To compare the duration of sensory and motor blockade produced by two different intrathecal doses of dexmedetomidine (5 µg and 10 µg) when added to hyperbaric bupivacaine in patients undergoing elective cesarean section
Trial Details
NCT Number NCT07395271
Lead Sponsor Bahria International Hospital
Conditions Dexmedetomidine
Enrollment 60 participants
Start Date 2025-10-22
Primary Completion 2026-01-21 (estimated)
Study Completion 2026-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-09